Randomized controlled trial: Moxibustion and acupuncture for the treatment of Crohn’s disease

Table 5 Results of the secondary outcome measures (n = 85) (mean ± SD)

Outcome measures	Group	Baseline	Post-treatment	Changes from baseline to post-treatment	P value
IBDQ	Treatment	157.67 ± 30.43	182.23 ± 33.07b	24.56 ± 34.15	0.017
	Control	157.36 ± 33.19	167.29 ± 29.85b	9.93 ± 19.13
HGB	Treatment	118.05 ± 17.79	123.14 ± 20.87a	5.09 ± 14.45	0.029
(g/L)	Control	124.79 ± 20.70	123.86 ± 21.23	-0.93 ± 10.07
ESR	Treatment	21.80 ± 16.86	17.85 ± 14.14	-3.77 ± 13.00	0.163
(mm/h)	Control	24.64 ± 22.28	24.41 ± 22.10	-0.21 ± 10.12
CRP	Treatment	18.52 ± 24.35	8.71 ± 8.94b	-8.67 ± 20.04	0.008
(mg/L)	Control	12.32 ± 13.43	13.60 ± 14.81	1.16 ± 12.11
CDEIS	Treatment	9.92 ± 8.94	7.64 ± 6.84	-2.28 ± 5.52	0.380
	Control	6.15 ± 3.90	5.54 ± 4.79	-0.60 ± 4.75
HS	Treatment	11.2 ± 1.47	9.00 ± 2.11b	-2.2 ± 2.21	0.029
	Control	11.07 ± 1.44	10.53 ± 2.13	-0.53 ± 1.73

P values from comparisons of changes from baseline to post treatment between the treatment and control groups (^aP < 0.05;

^bP < 0.01 vs control). IBDQ: Inflammatory bowel disease questionnaire; HGB: Hemoglobin; ESR: Erythrocyte sedimentation rate; CRP: C-reactive protein; CDEIS: Crohn’s disease endoscopic index of severity.